Earnings Releases·Nov 12, 2026, 7:00 AM ET

Aveanna Healthcare Holdings — Third Quarter 2026 Earnings Summary

Q3 revenue rose 11.8% YoY to $695.5 million, while net income surged to $45.5 million ($0.20/share) from $14.1 million ($0.06/share); Adjusted EBITDA increased 25.0% YoY to $100.1 million.
Full-year 2026 guidance was raised to revenue exceeding $2.695 billion (from >$2.68 billion) and Adjusted EBITDA exceeding $374 million (from >$365 million), driven by strong organic growth across all segments.
Nine-month free cash flow reached $141.2 million with net cash from operations at $157.5 million; total indebtedness stands at $1,521.3 million against $197.8 million in cash and $225.6 million of undrawn revolver capacity.
Management cited disciplined deleveraging and cost control, noting a 31.0% reduction in Q3 corporate expenses, while withholding net income guidance due to volatility in fair value adjustments.